Page 17 - Adicet Bio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Apellis Pharmaceuticals (NASDAQ:APLS – Free Report) and Adicet Bio (NASDAQ:ACET – Free Report) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, analyst recommendations, institutional ownership and earnings. Valuation and Earnings This table compares Apellis Pharmaceuticals and Adicet […]

Adicet Bio (NASDAQ:ACET – Free Report) had its target price cut by BTIG Research from $34.00 to $20.00 in a research note released on Tuesday morning, The Fly reports. A number of other equities analysts also recently weighed in on the stock. JPMorgan Chase & Co. downgraded shares of Adicet Bio from an overweight rating […]

Adicet Bio (NASDAQ:ACET – Free Report) had its target price lowered by BTIG Research from $34.00 to $20.00 in a research report report published on Tuesday, The Fly reports. A number of other equities analysts also recently weighed in on ACET. HC Wainwright reiterated a buy rating and issued a $38.00 target price on shares […]

Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer, today announced it granted inducement awards on June 30,...

30.06.2023 - Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer, today announced it granted inducement awards on June 30, 2023. Seven individuals were hired by ...